While the data from the transgenic mice suggested an important role of Becn1 levels on AD pathology [41], it was unclear if this effect is upstream of APP pathology or partially a consequence of disrupted intracellular trafficking due to APP overexpression. The gene discussed is BECN1; the disease is Alzheimer disease.